01 August 2005
NO(2)-induced acute and chronic lung injury cause imbalance of glutathionemetabolism in type II pneumocytes.
Renate Hochscheid, Ute Schuchmann, Elke Kotte, Stephan Kranz, Sven Heinrichs, Bernd MullerMed Sci Monit 2005; 11(8): BR273-279 :: ID: 200945
Abstract
Background: During inspiration the lung is exposed to numerous oxidantsand therefore has developed a system of antioxidant defense. This organ, besides the liver, is the majorsource of glutathione (GSH) metabolism, from which type II pneumocytes are metabolically the most activecells. Material/Methods: To analyze oxidative stress, rats were exposed to air (control) or to 10 ppmnitrogen dioxide (NO(2)) for 3 and 20 days to induce acute and chronic lung injury. As measure of oxidativestress, GSH/GSSG ratios in blood, bronchoalveolar lavage (BAL) and type II pneumocytes were determined.Lipid peroxidation (LPO) was also measured in type II cells. To investigate the basis of these observations,GSH metabolism in type II pneumocytes was studied, analyzing mRNA expression of g-glutamylcystein synthetase(gamma-GCS), glutathione synthetase (GS), gamma-glutamyltranspeptidase (gamma-GT), glutathione peroxidases(GPXs) and glutathione reductase (GR). Furthermore, enzyme activities of GPX and GR were determined.Results: In acute and chronic lung injury the GSH/GSSG ratio was reduced in blood and BAL, but therewas no change in type II pneumocytes. LPO in type II cells was only reduced in acute lung injury. Inboth kinds of lung injury mRNA expression of gamma-GCS, GS and GPX3 decreased, while expression of gamma-GTand GR increased. GPX4 mRNA expression decreased in acute lung injury and increased in the chronic state.Enzyme activity of GPX and GR was generally increased in lung injury. Conclusions: In NO(2) induced acuteand chronic lung injury, GSH metabolism is imbalanced.
Keywords: Chronic Disease, Enzymes - genetics, Glutathione - biosynthesis, Glutathione - metabolism, Glutathione Peroxidase - metabolism, Lung - drug effects, Lung - injuries, Lung - metabolism, Lung - pathology, Nitrogen Dioxide - toxicity, Oxidation-Reduction - drug effects, Oxidative Stress - drug effects, RNA, Messenger - genetics, RNA, Messenger - metabolism, Chronic Disease, Enzymes - genetics, Glutathione - metabolism, Glutathione Peroxidase - metabolism, Lung - pathology, Lung Injury, Nitrogen Dioxide - toxicity, Oxidation-Reduction - drug effects, Oxidative Stress - drug effects, RNA, Messenger - metabolism
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952